Connection
John Arcaroli to Drug Synergism
This is a "connection" page, showing publications John Arcaroli has written about Drug Synergism.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.118 |
|
|
|
-
Pitts TM, Newton TP, Bradshaw-Pierce EL, Addison R, Arcaroli JJ, Klauck PJ, Bagby SM, Hyatt SL, Purkey A, Tentler JJ, Tan AC, Messersmith WA, Eckhardt SG, Leong S. Dual pharmacological targeting of the MAP kinase and PI3K/mTOR pathway in preclinical models of colorectal cancer. PLoS One. 2014; 9(11):e113037.
Score: 0.106
-
Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, Shetty S, Idell S. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol. 2003 Jun 01; 170(11):5644-51.
Score: 0.012